Home / Intelligence / Webinars / Learn From the Past – Launch Better Tomorrow
Available On Demand
Whether you are an emerging, mid-tier or large-tier company preparing for launch, this webinar is a must-watch.
Join us for an informative webinar as our experts dive into Trinity Life Sciences’ latest white paper, the Trinity Annual Drug Index—an evaluation of commercial performance over three years of 58 novel drugs approved in 2020.
Hear from Blair Miller, Krista Perry, Hanson Koota and Smit Mahida from our Strategic Advisory practice as they discuss the impacts of COVID on the 2020 launch class. They will share key themes and emerging trends in the industry as we move towards a new world of targeted and innovative therapies.
Learn from drugs with outstanding performance and discover how to apply these learnings to launch better tomorrow.
In Case You Missed It
Click here to read our white paper entitled Trinity Annual Drug Index: Evaluating the Commercial Performances of Novel Drugs Approved in 2020.
Featuring
Blair Miller
Partner,
Strategic Advisory
Krista Perry
Partner &
Head of Launch Excellence
Hanson Koota
Associate Principal,
Strategic Advisory
Smit Mahida
Engagement Manager,
Strategic Advisory
Complete the form below to view the on-demand webinar
By submitting this form, creating an account, and/or using our website (or using our Services) you agree to our Privacy Policy. Information provided by you is stored in our database and may be used for sending you additional information about Trinity (including Trinity’s partners and affiliates) and our products and services. Such information may be transferred for this purpose to Trinity and affiliates in other countries. If you would like to opt out in the future, please email _compliance@trinitylifesciences.com.
This webinar will be hosted within the ON24 platform, which requires the usage of Javascript and Cookies. Please see ON24’s Privacy Policy for more information.
Related Intelligence
Webinars
Picking Winners: Portfolio Management for a New Era
May 30, 2024 | 1:00 – 1:45 PM ET
Two additional sessions will be offered: June 4, 2024 | 16:00-16:45 (UTC+8:00) – Asia/ShanghaiJune 4, 2024 | 15:00-15:45 CET – Europe/Berlin Did you know 62% of products launched between September 2019 and December 2021 underperformed expectations in the first year of launch? What is going wrong, and how can we get it right? Join Trinity Life […]
Sign Up Now
White Papers
Picking Winners: Portfolio Management for a New Era
The biopharmaceutical industry is known for its promise of life-changing innovations, but many companies continue to advance the wrong therapies into the clinic, resulting in underperformance and wasted resources. This white paper explores the concentration of activity on well-trodden ground, and the lack of focus on true innovation. With increasing global pricing pressures and policy […]
Read More
White Papers
Trinity Annual Drug Index
This report, the sixth in our Trinity Drug Index series, outlines key themes and emerging trends in the industry as we progress towards a new world of targeted and innovative products. We provide a comprehensive evaluation of the commercial performance over three years of novel drugs approved by the FDA in 2020, with commercial, therapeutic […]
Read More